Pages that link to "Q46578570"

The following pages link to Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment (Q46578570):

Displaying 35 items.

• Doxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes (Q30278879) (← links)
• Stress susceptibility-specific phenotype associated with different hippocampal transcriptomic responses to chronic tricyclic antidepressant treatment in mice (Q30557339) (← links)
• Chronic fluoxetine treatment in middle-aged rats induces changes in the expression of plasticity-related molecules and in neurogenesis. (Q34119432) (← links)
• Glutamatergic modulators: the future of treating mood disorders? (Q34398007) (← links)
• Developmental up-regulation of vesicular glutamate transporter-1 promotes neocortical presynaptic terminal development. (Q34506134) (← links)
• BDNF regulates the expression and distribution of vesicular glutamate transporters in cultured hippocampal neurons (Q34551784) (← links)
• Vesicular glutamate transporter VGLUT1 has a role in hippocampal long-term potentiation and spatial reversal learning (Q34609558) (← links)
• Characterization of the transporterB0AT3 (Slc6a17) in the rodent central nervous system (Q34721980) (← links)
• Glutamatergic drive of the dorsal raphe nucleus (Q35148291) (← links)
• Novel glutamatergic agents for major depressive disorder and bipolar disorder (Q35661119) (← links)
• Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trial (Q36029739) (← links)
• Neurodevelopmental role for VGLUT2 in pyramidal neuron plasticity, dendritic refinement, and in spatial learning (Q36410605) (← links)
• Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders (Q37143117) (← links)
• Remodeling of hippocampal spine synapses in the rat learned helplessness model of depression (Q37145540) (← links)
• Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder. (Q37159338) (← links)
• Synaptic vesicle protein trafficking at the glutamate synapse. (Q37160079) (← links)
• Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders (Q37481603) (← links)
• Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression (Q37710849) (← links)
• Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited (Q37891098) (← links)
• Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties (Q38203915) (← links)
• IRF2BP2-deficient microglia block the anxiolytic effect of enhanced postnatal care. (Q39311963) (← links)
• Increased expression of the Vesicular Glutamate Transporter-1 (VGLUT1) in the prefrontal cortex correlates with differential vulnerability to chronic stress in various mouse strains: Effects of fluoxetine and MK-801 (Q39704362) (← links)
• Altered Functionality, Morphology, and Vesicular Glutamate Transporter Expression of Cortical Motor Neurons from a Presymptomatic Mouse Model of Amyotrophic Lateral Sclerosis. (Q41570562) (← links)
• Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration. (Q41597368) (← links)
• Targeting glial physiology and glutamate cycling in the treatment of depression (Q42056797) (← links)
• Co-localization of corticotropin-releasing factor and vesicular glutamate transporters within axon terminals of the rat dorsal raphe nucleus (Q42146632) (← links)
• Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm (Q43199179) (← links)
• A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity (Q48348498) (← links)
• GLT-1 down-regulation induced by clozapine in rat frontal cortex is associated with synaptophysin up-regulation (Q48417444) (← links)
• Fluoxetine treatment induces EAAT2 expression in rat brain (Q48946272) (← links)
• Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine (Q49083634) (← links)
• Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons (Q50031789) (← links)
• Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers (Q58480160) (← links)
• Genetic findings in sport-related concussions: potential for individualized medicine? (Q64950808) (← links)
• Octopamine neuron dependent aggression requires dVGLUT from dual-transmitting neurons (Q89876170) (← links)